Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Foie gras can speed amyloid development

Foie gras can speed amyloid development

Transplantation does not benefit patients with refractory myeloma

Transplantation does not benefit patients with refractory myeloma

Revlimid may change the way physicians treat multiple myeloma

Revlimid may change the way physicians treat multiple myeloma

Scientists develop a more human-like mouse model of cancer

Scientists develop a more human-like mouse model of cancer

FDA approves VELCADE plus DOXIL combination for multiple myeloma

FDA approves VELCADE plus DOXIL combination for multiple myeloma

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Multiple myeloma dexamethasone / lenalidomide trial closes

Multiple myeloma dexamethasone / lenalidomide trial closes

Novel targeted therapy effectively treats acute leukemia

Novel targeted therapy effectively treats acute leukemia

Avalon Pharmaceuticals announces results of  AVN944 biomarker study

Avalon Pharmaceuticals announces results of AVN944 biomarker study

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Chaetocin shows promise as a new anti-myeloma agent

Chaetocin shows promise as a new anti-myeloma agent

Lower doses of dexamethasone for multiple myeloma recommended

Lower doses of dexamethasone for multiple myeloma recommended

Multiple myeloma trial has shows significant improvement in survival

Multiple myeloma trial has shows significant improvement in survival

Recognition for cancer researchers

Recognition for cancer researchers

Immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease

Immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease

Immune response to cancer stem cells may dictate cancer's course

Immune response to cancer stem cells may dictate cancer's course

Two novel therapies for multiple myeloma

Two novel therapies for multiple myeloma

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic tests engineered measles virus against multiple myeloma

Researchers wake up viruses inside tumors to image and then destroy cancers

Researchers wake up viruses inside tumors to image and then destroy cancers

Chemotherapy drug bortezomib packs a one-two punch

Chemotherapy drug bortezomib packs a one-two punch